Previsioni di mercato dei servizi di metabolomica in Europa fino al 2028 - Impatto del COVID-19 e analisi regionale per tipo di servizio (servizio di metabolomica mirato e servizio di metabolomica non mirato) e applicazione (industria farmaceutica e biotecnologica, agricoltura e ambiente)
Introduzione al mercato
Il mercato europeo dei servizi di metabolomica è diviso in Germania, Regno Unito, Francia , Italia, Spagna e Resto d\'Europa. La regione detiene una quota di mercato significativa nel mercato dei servizi di metabolomica. L’Europa occupa una posizione significativa nel mercato dei servizi di metabolomica e si stima che registrerà un robusto tasso di crescita nel periodo di previsione. La crescita del mercato nella regione è prevista grazie alla crescente ricerca nel campo delle scienze della vita e all’aumento degli investimenti in ricerca e sviluppo. La Germania detiene una quota di mercato nella regione europea in quanto ha il più grande settore di ricerca medica nella regione europea ed è il terzo più grande nel mondo. Si prevede che il paese dominerà il settore più significativo della ricerca medica durante il periodo di previsione. Inoltre, negli ultimi anni la Germania ha assistito a un enorme aumento dei casi di cancro; ad esempio, secondo il Global Cancer Observatory, nel 2020 sono stati riscontrati un totale di 6.28.519 nuovi casi in entrambi i sessi e di tutte le età, insieme a casi di 69.697 (11,1%) casi di cancro al seno, 67.959 (10,8%) Cancro alla prostata, 64.804 (10,3%) cancro al polmone, 57.528 (9,2%) cancro del colon-retto, 35.147 (5,6%) cancro alla vescica e 333.384 (53%) altri tumori. I servizi di metabolomica sono ampiamente utilizzati per rilevare un\'ampia gamma di metaboliti nei tessuti e nei biofluidi; pertanto, la domanda di servizi di metabolomica è in aumento nel paese. L\'aumento dell\'adozione della metabolomica e degli investimenti da parte degli operatori del mercato è il fattore principale che guida la crescita del mercato dei servizi di metabolomica in Europa.
Il mercato dei servizi di metabolomica in Europa, in base al tipo di servizio, è segmentato in servizio di metabolomica mirata e servizio di metabolomica non mirata. Il segmento dei servizi di metabolomica mirata ha guidato il mercato nel 2020. La metabolomica mirata è un metodo quantitativo che prevede la stima di un gruppo di metaboliti con l\'aiuto di composti 15N o 13C. Diverse aziende offrono servizi di metabolomica mirati. Quantificando le piccole molecole e confrontandole con standard stabiliti, possono indirizzare i servizi di metabolomica per osservare con precisione il processo metabolico dinamico, rivelare meccanismi metabolici appropriati e verificare possibili biomarcatori metabolici. Utilizzando sistemi e tecniche LC-MS/MS all\'avanguardia, i fornitori di servizi metabolici offrono flussi di lavoro convalidati di metabolomica mirata come vitamine, aminoacidi, ormoni e molte piccole molecole.
Panoramica e dinamiche del mercato
Si prevede che il mercato dei servizi di metabolomica in Europa crescerà da 128,72 dollari USA milioni di dollari nel 2021 a 484,02 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 20,8% dal 2021 al 2028. Gli attori del mercato associati alla metabolomica stanno esplorando attivamente le possibili tecnologie innovative per facilitare i ricercatori e l\'assistenza medica. I biomarcatori hanno una vasta applicazione nella terapia personalizzata contro il cancro. Inoltre, gli operatori del mercato stanno esplorando metodi e tecnologie avanzati per applicazioni diagnostiche. Ad esempio, nell\'aprile 2021, IMAGEENS, una startup di intelligenza artificiale (AI) medica con sede a Parigi, ha accelerato lo sviluppo e la commercializzazione di ArtFun+, un software di intelligenza artificiale e i suoi biomarcatori prognostici per l\'imaging cardiovascolare, e ha raccolto finanziamenti di € 1,2 milioni per lo stesso. Pertanto, si prevede che tali approcci innovativi da parte degli operatori del mercato aprano nuove possibilità per il mercato.
Segmenti chiave del mercato
Il mercato dei servizi di metabolomica in Europa è stato segmentato in base al tipo di servizio, all\'applicazione e al paese. Sulla base del tipo di servizio, il mercato dei servizi di metabolomica in Europa è segmentato in servizio di metabolomica mirato e servizio di metabolomica non mirato. Il segmento dei servizi di metabolomica mirato ha dominato il mercato nel 2020 e si prevede che sarà quello in più rapida crescita durante il periodo di previsione. In base all’applicazione, il mercato è segmentato nell’industria farmaceutica e biotecnologica, nell’agritech e nell’ambiente. Il segmento dell’industria farmaceutica e biotecnologica ha dominato il mercato nel 2020 e si prevede che registrerà la crescita più rapida durante il periodo di previsione. Allo stesso modo, il settore farmaceutico e biotecnologico segmentato è classificato in scoperta di biomarcatori, scoperta di farmaci, test tossicologici e altri.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato dei servizi di metabolomica in Europa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Afekta Technologies Ltd.; BASF SE; biocrates scienze della vita ag; Proteomica Creativa; Centro di ricerca sul cancro Fred Hutchinson; Metabolone, Inc.; metaSysX; MS-Omics; e RTI International sono tra gli altri.
Motivi per acquistare il rapporto
- Comprendere il panorama del mercato europeo dei servizi di metabolomica e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
- Stai al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il mercato europeo dei servizi di metabolomica
- Pianifica in modo efficiente fusioni e acquisizioni e accordi di partnership nel mercato europeo dei servizi di metabolomica identificando i segmenti di mercato con le vendite probabili più promettenti
- Aiuta a prendere decisioni aziendali consapevoli attraverso un\'analisi percettiva e completa delle prestazioni di mercato dei vari segmenti dall\'Europa mercato dei servizi di metabolomica
- Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 nella regione europea.
Segmentazione del mercato dei servizi di metabolomica in Europa
Metabolomica in Europa Mercato dei servizi: pertipo di servizio
- Servizio di metabolomica mirata
- Servizio di metabolomica non mirato
Mercato europeo dei servizi di metabolomica - per applicazione
- Industria farmaceutica e biotecnologica
- Scoperta di biomarcatori
- Scoperta di farmaci
- Test tossicologici
- Altro
- Agritech
- Ambiente
Mercato europeo dei servizi di metabolomica - Per paese
- Stati Uniti
- Canada
- Messico
Mercato europeo dei servizi di metabolomica -Profili aziendali
- Germania
- Francia
- Regno Unito
- Italia
- Spagna
- Resto d\'Europa
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Metabolomics Services Market – By Service Type
1.3.2 Europe Metabolomics Services Market – By Application
1.3.3 Europe Metabolomics Services Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Metabolomics Services Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Metabolomics Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Uprising Incidences of Cancer
5.1.2 Rise in Adoption of Metabolomics and Investments by Market Players
5.2 Market Restraints
5.2.1 High Cost of Tools, Instruments, and Usage
5.3 Market Opportunities
5.3.1 Growth Opportunities in Several Countries
5.4 Future Trends
5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
5.5 Impact Analysis
6. Metabolomics Services Market– Europe Analysis
6.1 Europe Metabolomics Services Market Revenue Forecast and Analysis
7. Europe Metabolomics Services Market Revenue and Forecasts to 2028– by Service Type
7.1 Overview
7.2 Europe Metabolomics Services Market, By Service Type 2021 & 2028 (%)
7.3 Targeted Metabolomics Service
7.3.1 Overview
7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Untargeted Metabolomics Service
7.4.1 Overview
7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Metabolomics Services Market Revenue and Forecasts to 2028 – by Application
8.1 Overview
8.2 Europe Metabolomics Services Market Share by Application 2021 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Industry
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.1 Biomarker Discovery
8.3.2.1.1 Overview
8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.2 Toxicological Testing
8.3.2.2.1 Overview
8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.3 Drug Discovery
8.3.2.3.1 Overview
8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.4 Others
8.3.2.4.1 Overview
8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Agritech
8.4.1 Overview
8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Environment
8.5.1 Overview
8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Metabolomics Services Market Revenue and Forecasts to 2028 – Country Analysis
9.1.1 Europe: Metabolomics Services Market, by Country, 2021 & 2028(%)
9.1.1.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3.1 Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.2 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3.1 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3.1 UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.4 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3.1 Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.5 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3.1 Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.6 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3.1 Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Metabolomics Services Market
10.1 Overview
11. Europe Metabolomics Services Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 BASF SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Proteomics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 RTI International
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Afekta Technologies Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fred Hutchinson Cancer Research Center
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Metabolon, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 biocrates life sciences ag
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 metaSysX
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MS-Omics
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Metabolomics Services Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 5. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 11. Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 14. Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 20. organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, Metabolomics Services Market
LIST OF FIGURES
Figure 1. Europe Metabolomics Services Market Segmentation
Figure 2. Europe Metabolomics Services Market, By Country
Figure 3. Europe Metabolomics Services Market Overview
Figure 4. Targeted Metabolomics Service Segment Held Largest Share of Type Segment in Europe Metabolomics Services Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Impact Analysis of Drivers and Restraints Pertaining to Metabolomics Services Market
Figure 9. Europe Metabolomics Services Market– By Revenue Forecast and Analysis – 2019- 2028
Figure 10. Europe Metabolomics Services Market, by Service Type 2021 & 2028 (%)
Figure 11. Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Metabolomics Services Market Share by Application 2021 & 2028 (%)
Figure 14. Europe Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 15. Europe Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 16. Europe Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 17. Europe Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 18. Europe Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. Europe Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. Europe Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Europe: Metabolomics Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Europe: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 23. Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in European Country Markets
- Afekta Technologies Ltd.
- BASF SE
- biocrates life sciences ag
- Creative Proteomics
- Fred Hutchinson Cancer Research Center
- Metabolon, Inc.
- metaSysX
- MS-Omics
- RTI International
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Metabolomics Services market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe Metabolomics Services market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Metabolomics Services market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution